FIELD: biotechnology.
SUBSTANCE: invention relates to a protein which specifically binds to TGFβ1, and can be used in medicine. TGFβ1 binding protein, is an IgG or Fab-fragment of IgG and can be used for therapeutic and diagnostic purposes.
EFFECT: modified IgG antibodies which bind to a transforming growth factor beta-1 with high affinity, avidity and specificity.
13 cl, 9 dwg, 7 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODIES TARGETING BONE | 2018 |
|
RU2801206C2 |
| SCFV-FC DIMERS WHICH BIND TO THE TRANSFORMING GROWTH FACTOR β1 WITH HIGH AFFINITY, AVIDITY AND SPECIFICITY | 2016 |
|
RU2733286C2 |
| ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018 |
|
RU2795485C2 |
| ANTIBODY FOR SPECIFIC BINDING TO N-TERMINAL DOMAIN OF LYSYL-TRNA SYNTHETASE EXPOSED ON EXTRACELLULAR MEMBRANE | 2019 |
|
RU2781304C1 |
| HUMAN ANTIBODIES BINDING TO ROR2 | 2018 |
|
RU2784586C2 |
| ANTIBODIES AGAINST ANGPTL3/8 COMPLEX AND THEIR APPLICATION METHODS | 2019 |
|
RU2791034C2 |
| ANTI-SIRPα ANTIBODIES | 2018 |
|
RU2771174C2 |
| CD47-ANTIGEN-BINDING UNIT AND ITS USE | 2018 |
|
RU2780859C2 |
| ANTIBODIES AGAINST XI CLOTTING FACTOR | 2017 |
|
RU2757314C2 |
| ANTIBODIES CONTAINING POLYPEPTIDE INTEGRATED INTO FRAME REGION 3 | 2019 |
|
RU2796254C2 |
